Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) EBT (2020 - 2026)

Trulieve Cannabis has reported EBT over the past 6 years, most recently at $2.9 million for Q4 2025.

  • For Q4 2025, EBT rose 122.79% year-over-year to $2.9 million; the TTM value through Dec 2025 reached $91.5 million, up 114.15%, while the annual FY2025 figure was $91.5 million, 114.15% up from the prior year.
  • EBT for Q4 2025 was $2.9 million at Trulieve Cannabis, down from $29.3 million in the prior quarter.
  • Over five years, EBT peaked at $70.0 million in Q2 2021 and troughed at -$308.2 million in Q2 2023.
  • A 5-year average of $174350.0 and a median of $13.4 million in 2022 define the central range for EBT.
  • Biggest five-year swings in EBT: crashed 1265.17% in 2023 and later surged 2644.5% in 2024.
  • Year by year, EBT stood at -$18.6 million in 2021, then increased by 5.22% to -$17.6 million in 2022, then surged by 150.09% to $8.8 million in 2023, then plummeted by 246.25% to -$12.9 million in 2024, then skyrocketed by 122.79% to $2.9 million in 2025.
  • Business Quant data shows EBT for TCNNF at $2.9 million in Q4 2025, $29.3 million in Q3 2025, and $38.9 million in Q2 2025.